Skip to main content
Premium Trial:

Request an Annual Quote

Vela Genomics NGS Clinical Interpretation and Reporting

Vela Genomics, a subsidiary of Vela Diagnostics, has launched TheraKey, a cloud-based, HIPAA-compliant, next-generation sequencing clinical interpretation and reporting solution. The TheraKey database includes somatic cancer mutations in more than 800 genes, sourced from approximately 220,000 clinical trials for about 2,000 cancer drugs. It also offers natural language processing to facilitate reporting of actionable treatments, including off-label, investigational, and combination therapies for specific diseases or gene variants. The firm will also offer TheraKey as part of its Sentosa NGS workflow for Oncology.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.